Rockland Trust’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Rockland Trust’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,143	Closed	-$9K	–	163
2017 Q2	$9K	Hold	2,143	–	–	﹤0.01%	161
2017 Q1	$10K	Hold	2,143	–	–	﹤0.01%	158
2016 Q4	$5K	Hold	2,143	–	–	﹤0.01%	161
2016 Q3	$6K	Hold	2,143	–	–	﹤0.01%	155
2016 Q2	$5K	Hold	2,143	–	–	﹤0.01%	155
2016 Q1	$6K	Hold	2,143	–	–	﹤0.01%	151
2015 Q4	$18K	Hold	2,143	–	–	﹤0.01%	159
2015 Q3	$15K	Hold	2,143	–	–	﹤0.01%	149
2015 Q2	$20K	Hold	2,143	–	–	﹤0.01%	140
2015 Q1	$20K	Hold	2,143	–	–	﹤0.01%	137
2014 Q4	$21K	Hold	2,143	–	–	﹤0.01%	145
2014 Q3	$20K	Hold	2,143	–	–	﹤0.01%	126
2014 Q2	$28K	Hold	2,143	–	–	0.01%	124
2014 Q1	$29K	Buy	+2,143	New	+$28.2K	0.01%	123

Other funds holding CDMO

TSP

Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

Rockland Trust's CDMO Position: Q3 2017 in Review

Rockland Trust sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2017, closing a stake of 2,143 shares — an estimated $9K sold.

Rockland Trust first reported a position in CDMO in Q1 2014 and held it in 14 quarters. The position peaked at $29K in Q1 2014. 53 funds tracked by Wall St. Rank hold CDMO as of Q3 2017.

Rockland Trust reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
Rockland Trust sold 2,143 Avid Bioservices, Inc. Common Stock shares in Q3 2017, an estimated $9K.
Rockland Trust first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2014 and held it in 14 quarters.
Rockland Trust's Avid Bioservices, Inc. Common Stock position peaked at $29K in Q1 2014.
53 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2017.

Based on Rockland Trust's 13F filing for Q3 2017, filed 1 Nov 2017.